The Journal of Organic Chemistry
Article
4.26−4.17 (m, 4H), 2.22 (s, 3H), 1.87 (s, 3H), 1.30 (t, J = 7.5 Hz, 3H),
and 1.21 (t, J = 7.5 Hz, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ
200.9, 174.1, 172.3, 168.2, 134.5, 133.7, 132.9, 132.6, 131.1, 130.7,
129.1, 128.3, 103.3, 64.9, 61.7, 60.8, 28.9, 19.9, 14.2, and 14.1.
colorless oil (0.29 g, 55%) from the reaction of 2-acetonaphthone (0.52
g, 3.04 mmol, 1.0 equiv) and EDA (0.73 mL, 6.07 mmol, 2.0 equiv) in
•
1
the presence of HBF4 OEt2 (0.084 mL, 0.61 mmol, 0.2 equiv). H
NMR (CDCl3, 500 MHz): δ 13.22 (s, 1H), 7.90−7.83 (m, 7H), 7.65 (s,
1H), 7.55−7.49 (m, 5H), 7.31 (d, J = 10.0 Hz, 1H), 4.89 (s, 1H), 4.31−
4.19 (m, 4H), 2.25 (s, 3H), 1.92 (s, 3H), 1.32 (t, J = 7.5 Hz, 3H), and
1.19 (t, J = 7.5 Hz, 3H). 13C{1H} NMR (CDCl3, 75 MHz): δ 201.7,
174.2, 172.7, 168.6, 133.4, 133.3, 133.0, 132.8, 132.4, 130.2, 130.0,
129.6, 128.7, 128.7, 128.0, 127.9, 127.7, 127.5, 126.7, 126.5, 126.4,
126.0, 125.9, 104.3, 65.9, 61.7, 60.7, 28.9, 20.0, 14.2, and 14.1.
Ethyl 2-(4-Methoxyphenyl)-3-oxobutanoate (Keto-enol = 4:3)
(3c).21 The compound was prepared according to the general
procedure and purified by silica gel column chromatography
(hexane/ethyl acetate = 50:1). The title product was isolated as a
colorless oil (0.52 g, 64%) from the reaction of 4′-methoxyacetophe-
none (0.51 g, 3.41 mmol, 1.0 equiv) and EDA (0.82 mL, 6.82 mmol, 2.0
•
equiv) in the presence of HBF4 OEt2 (0.09 mL, 0.68 mmol, 0.2 equiv).
Ethyl 3-Oxo-2-phenylpentanoate (Keto-enol = 6:5) (5a). The
compound was prepared according to the general procedure and
purified by silica gel column chromatography (hexane/ethyl acetate =
100:1). The title product was isolated as a colorless oil (0.58 g, 34%)
from the reaction of propiophenone (0.52 g, 3.88 mmol, 1.0 equiv) and
1H NMR (CDCl3, 300 MHz): δ 13.11 (s, 1H), 7.28 (d, J = 6.0 Hz, 2H),
7.08 (t, J = 4.5 Hz, 2H), 7.28 (t, J = 9.0 Hz, 4H), 4.65 (s, 1H), 4.20 (q, J
= 7.5 Hz, 4H), 3.82 (s, 3H), 3.81 (s, 3H), 2.18 (s, 3H), 1.86 (s, 3H),
1.28 (t, J = 7.5 Hz, 3H), and 1.19 (t, J = 7.5 Hz, 3H). 13C{1H} NMR
(CDCl3, 75 MHz): δ 201.8, 174.0, 172.8, 168.8, 159.6, 158.5, 132.2,
130.4, 127.9, 127.5, 124.8, 114.3, 113.5, 103.8, 64.9, 61.5, 60.6, 55.2,
55.1, 28.6, 19.8, 14.2, and 14.1.
•
EDA (0.94 mL, 7.75 mmol, 2.0 equiv) in the presence of HBF4 OEt2
(0.11 mL, 0.78 mmol, 0.2 equiv). 1H NMR (CDCl3, 300 MHz): δ 13.23
(s, 1H), 7.37−28 (m, 8H), 7.18 (t, J = 4.5 Hz, 2H), 4.76 (s, 1H), 4.26−
4.14 (m, 4H), 2.53 (q, J = 6.0 Hz, 2H), 2.15 (q, J = 6.0 Hz, 2H), 1.28 (t, J
= 7.5 Hz, 3H), 1.18 (t, J = 7.5 Hz, 3H), and 1.12−1.01 (m, 6H).
13C{1H} NMR (CDCl3, 75 MHz): δ 204.2, 178.1, 172.8, 168.7, 135.2,
133.0, 131.2, 129.4, 128.8, 128.1, 128.0, 126.9, 103.6, 64.8, 61.5, 60.5,
34.9, 26.3, 14.2, 14.0, 11.1, and 7.8. HRMS (ESI/Q-TOF): calculated
(m/z) for C13H17O3 (M + H)+: 221.1172; found 221.1164.
Ethyl 3-Oxo-2-(p-tolyl)butanoate (Keto-enol = 2:1) (3d).22 The
compound was prepared according to the general procedure and
purified by silica gel column chromatography (hexane/ethyl acetate =
100:1). The title product was isolated as a colorless oil (0.30 g, 58%)
from the reaction of 4′-methylacetophenone (0.53 g, 3.91 mmol, 1.0
equiv) and EDA (0.95 mL, 7.83 mmol, 2.0 equiv) in the presence of
•
HBF4 OEt2 (0.11 mL, 0.78 mmol, 0.2 equiv). 1H NMR (CDCl3, 300
Ethyl 2-Benzoylbutanoate (5a′).24 The compound was prepared
according to the general procedure and purified by silica gel column
chromatography (hexane/ethyl acetate = 100:1). The title product was
isolated as a colorless oil (0.48 g, 28%) from the reaction of
propiophenone (0.52 g, 3.88 mmol, 1.0 equiv) and EDA (0.94 mL,
MHz): δ 13.14 (s, 1H), 7.27−7.15 (m, 8H), 7.06 (d, J = 6.0 Hz, 2H),
4.67 (s, 1H), 4.28−4.16 (m, 4H), 2.38 (s, 3H), 2.37 (s, 3H), 2.20 (s,
3H), 1.87 (s, 3H), 1.30 (t, J = 7.5 Hz, 3H), and 1.22 (t, J = 6.0 Hz, 3H).
13C{1H} NMR (CDCl3, 125 MHz): δ 201.8, 173.8, 172.8, 168.7, 138.1,
136.5, 132.2, 131.1, 129.7, 129.6, 129.1, 128.8, 104.1, 65.4, 61.6, 60.6,
28.7, 21.2, 21.1, 20.0, 14.2, and 14.1.
•
7.75 mmol, 2.0 equiv) in the presence of HBF4 OEt2 (0.11 mL, 0.78
mmol, 0.2 equiv). 1H NMR (CDCl3, 300 MHz): δ 7.98 (d, J = 9.0 Hz,
2H), 7.55 (t, J = 6.0 Hz, 1H), 7.48 (t, J = 6.0 Hz, 2H), 4.21 (t, J = 6.0 Hz,
1H), 4.12 (q, J = 9.0 Hz, 2H), 2.07−1.98 (m, 2H), 1.14 (t, J = 6.0 Hz,
3H), and 0.98 (t, J = 7.5 Hz, 3H). 13C{1H} NMR (CDCl3, 75 MHz): δ
195.2, 169.9, 136.4, 133.4, 128.7, 128.5, 61.2, 55.8, 22.4, 14.0, and 12.1.
Ethyl 3-Oxo-2-phenylhexanoate (Keto-enol = 2:3) (5b). The
compound was prepared according to the general procedure and
purified by silica gel column chromatography (hexane/ethyl acetate =
100:1). The title product was isolated as a colorless oil (0.59 g, 36%)
from the reaction of butyrophenone (0.52 g, 3.50 mmol, 1.0 equiv) and
Ethyl 3-Oxo-2-(m-tolyl)butanoate (Keto-enol = 3:4) (3e).23 The
compound was prepared according to the general procedure and
purified by silica gel column chromatography (hexane/ethyl acetate =
100:1). The title product was isolated as a colorless oil (0.21 g, 40%)
from the reaction of 3′-methylacetophenone (0.52 g, 3.85 mmol, 1.0
equiv) and EDA (0.93 mL, 7.69 mmol, 2.0 equiv) in the presence of
•
HBF4 OEt2 (0.11 mL, 0.77 mmol, 0.2 equiv). 1H NMR (CDCl3, 300
MHz): δ 13.15 (s, 1H), 7.28−7.10 (m, 8H), 7.06 (d, J = 9.0 Hz, 2H),
4.68 (s, 1H), 4.27−4.17 (m, 4H), 2.38 (s, 6H), 2.21 (s, 3H), 1.88 (s,
3H), 1.30 (t, J = 7.5 Hz, 3H), and 1.22 (t, J = 7.5 Hz, 3H). 13C{1H}
NMR (CDCl3, 125 MHz): δ 201.7, 173.8, 172.7, 168.6, 138.6, 137.5,
135.1, 132.6, 131.9, 129.9, 129.0, 128.8, 128.3, 127.9, 127.7, 126.3,
104.4, 65.7, 61.5, 60.6, 28.7, 21.4, 19.9, 14.2, and 14.1.
•
EDA (0.85 mL, 7.0 mmol, 2.0 equiv) in the presence of HBF4 OEt2
1
(0.096 mL, 0.70 mmol, 0.2 equiv). H NMR (CDCl3, 300 MHz): δ
13.20 (s, 1H), 7.40−7.30 (m, 8H), 7.18 (d, J = 5.0 Hz, 2H), 4.74 (s,
1H), 4.27−4.17 (m, 4H), 2.48 (t, J = 7.5 Hz, 2H), 2.11 (t, J = 8.0 Hz,
2H), 1.63−1.55 (m, 4H), 1.29 (t, J = 6.0 Hz, 3H), 1.19 (t, J = 6.0 Hz,
3H), and 0.89−0.83 (m, 6H). 13C{1H} NMR (CDCl3, 75 MHz): δ
203.7, 176.9, 172.9, 168.6, 135.2, 132.8, 131.4, 129.5, 128.8, 128.2,
128.0, 126.9, 104.3, 65.0, 61.6, 60.6, 43.5, 34.7, 20.1, 17.1, 14.2, 14.1,
13.8, and 13.4. HRMS (ESI/Q-TOF): calculated (m/z) for C14H19O3
(M + H)+: 235.1329; found 235.1312.
Ethyl 3-Oxo-2-(o-tolyl)butanoate (Keto-enol = 1:4) (3f).22 The
compound was prepared according to the general procedure and
purified by silica gel column chromatography (hexane/ethyl acetate =
100:1). The title product was isolated as a colorless oil (0.26 g, 48%)
from the reaction of 2′-methylacetophenone (0.53 g, 4.00 mmol, 1.0
equiv) and EDA (0.95 mL, 7.90 mmol, 2.0 equiv) in the presence of
Ethyl 2-Benzoylpentanoate (5b′).25 The compound was prepared
according to the general procedure and purified by silica gel column
chromatography (hexane/ethyl acetate = 100:1). The title product was
isolated as a colorless oil (0.39 g, 24%) from the reaction of
butyrophenone (0.52 g, 3.50 mmol, 1.0 equiv) and EDA (0.85 mL,
•
HBF4 OEt2 (0.11 mL, 0.79 mmol, 0.2 equiv). 1H NMR (CDCl3, 300
MHz): δ 13.10 (s, 0.8H), 7.72 (d, J = 9.0 Hz, 2H), 7.39 (d, J = 6.0 Hz,
2H), 7.25 (d, J = 6.0 Hz, 4H), 7.09 (s, 1H), 4.94 (s, 0.2H), 4.29−4.23
(m, 2H), 4.16−4.10 (m, 1H), 2.61 (s, 3H), 2.57 (s, 3H), 2.20 (s, 3H),
1.78 (s, 3H), 1.30 (s, 3H), and 1.22 (t, J = 7.5 Hz, 3H).
•
Ethyl 2-(4-Nitrophenyl)-3-oxobutanoate (Keto-enol = 4:5) (3g).21
The compound was prepared according to the general procedure and
purified by silica gel column chromatography (hexane/ethyl acetate =
25:1). The title product was isolated as a colorless oil (0.078 g, 15%)
from the reaction of 4′-nitroacetophenone (0.52 g, 3.12 mmol, 1.0
equiv) and EDA (0.75 mL, 6.24 mmol, 2.0 equiv) in the presence of
7.0 mmol, 2.0 equiv) in the presence of HBF4 OEt2 (0.096 mL, 0.70
mmol, 0.2 equiv). 1H NMR (CDCl3, 300 MHz): δ 7.98 (t, J = 4.5 Hz,
2H), 7.55 (t, J = 7.5 Hz, 1H), 7.48 (t, J = 7.5 Hz, 2H), 4.31 (t, J = 7.5 Hz,
1H), 4.15 (q, J = 6.0 Hz, 2H), 2.04−1.95 (m, 2H), 1.43−1.33 (m, 2H),
1.17 (t, J = 7.5 Hz, 3H), and 0.95 (t, J = 7.5 Hz, 3H).
Ethyl 3-Oxo-2-phenylheptanoate (Keto-enol = 7:2) (5c). The
compound was prepared according to the general procedure and
purified by silica gel column chromatography (hexane/ethyl acetate =
100:1). The title product was isolated as a colorless oil (0.24 g, 30%)
from the reaction of valerophenone (0.53 g, 3.27 mmol, 1.0 equiv) and
•
HBF4 OEt2 (0.085 mL, 0.62 mmol, 0.2 equiv). 1H NMR (CDCl3, 300
MHz): δ 13.25 (s, 1H), 8.36−8.20 (m, 3H), 7.83 (t, J = 4.5 Hz, 1H),
7.61−7.48 (m, 3H), 7.37 (d, J = 9.0 Hz, 1H), 4.85 (s, 1H), 4.30−4.18
(m, 4H), 2.29 (s, 3H), 1.91 (s, 3H), 1.31 (t, J = 7.5 Hz, 3H), and 1.21 (t,
J = 7.5 Hz, 3H).
Ethyl 2-(Naphthalen-2-yl)-3-oxobutanoate (Keto-enol = 5:3)
(3h).23 The compound was prepared according to the general
procedure and purified by silica gel column chromatography
(hexane/ethyl acetate = 50:1). The title product was isolated as a
•
EDA (0.79 mL, 6.53 mmol, 2.0 equiv) in the presence of HBF4 OEt2
1
(0.089 mL, 0.65 mmol, 0.2 equiv). H NMR (CDCl3, 300 MHz): δ
13.20 (s, 0.4H), 8.15 (d, J = 5.0 Hz, 1H), 7.51 (t, J = 5.0 Hz, 1H), 7.51−
7.35 (m, 7H), 7.17 (d, J = 5.0 Hz, 1H), 4.73 (s, 1.3H), 4.30−4.16 (m,
4H), 2.49 (t, J = 7.5 Hz, 2H), 2.12 (t, J = 7.5 Hz, 2H), 1.56−1.53 (m,
6143
J. Org. Chem. 2021, 86, 6138−6147